Cross-Border Strategy. Integrated Execution. Real Progress.

JRC is a cross-border biotech development and advisory firm built to help innovation move faster—from early-stage discovery to regulatory approval, clinical execution, and commercial dealmaking.

We partner with biotech companies across the U.S. and Asia-Pacific to overcome execution gaps, accelerate timelines, and prepare assets for investment, licensing, and market access. Our unique strength lies in combining U.S.-based regulatory and clinical expertise with high-efficiency APAC development networks, supported by a team of experienced consultants, former regulators, and transaction leaders.

Our core value lies in execution. We don’t just advise—we co-develop, coordinate, and deliver.

Whether you’re an emerging biotech in the U.S. looking to expand your clinical program globally, or an APAC innovator entering the U.S. market, JRC provides integrated solutions that align scientific, regulatory, and commercial priorities—turning potential into tangible progress.

Your innovation deserves more than advice. It deserves a path forward.

Led by experts. Built for action.

JRC brings together a global team of seasoned professionals in drug development, regulatory affairs, clinical operations, market access, and business development.

Our leadership includes experienced biotech consultants, cross-border transaction specialists, former regulatory advisors, and KOLs from top academic institutions and trial networks.

What unites our team is not just experience—but a shared commitment to execution. We work hands-on alongside our clients to design realistic plans, coordinate across functions and geographies, and drive toward concrete milestones.